Monoaminergic drugs for motor recovery after ischemic stroke;Médicaments monoaminergiques dans la récupération motrice après accident vasculaire cérébral ischémique

Annals of Physical and Rehabilitation Medicine

Volumn 57, Issue 8, 2014, Pages 509-519

  Chollet, F ^a   Tardy, J ^a   Albucher, J F ^a   Raposo, N ^a   Acket, B ^a   Sattler, V ^a   Pariente, J ^a   Loubinoux, I ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Brain plasticity; Fluoxetine; Monoaminergic drugs; Recovery; Stroke

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

BRAIN ISCHEMIA; DEPRESSION; FUNCTIONAL ASSESSMENT; HUMAN; MONOAMINERGIC SYSTEM; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; SHORT SURVEY; STROKE PATIENT; CONVALESCENCE; DRUG EFFECTS; STROKE;

HUMANS; NEURONAL PLASTICITY; RECOVERY OF FUNCTION; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 84911903892     PISSN: 18770657     EISSN: 18770665     Source Type: Journal    
DOI: 10.1016/j.rehab.2014.08.002     Document Type: Short Survey

References (32)

1. Schallert T., Jones T.A., Weaver M.S., Shapiro L.E., Crippens D., Fulton R. Pharmacologic and anatomic considerations in recovery of function. Phys Med Rehabil 1992, 6:375-393.
2. Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol 2008, 21:639-643.
3. Loubinoux I., Chollet F. Neuropharmacology in stroke recovery. Brain repair after stroke 2010, 183-193. Cambridge University Press, Cambridge. S.C. Cramer, R.J. Nudo (Eds.).
4. Windle V., Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res 2005, 1044:25-32. [Epub 2005Apr7].
5. Goldstein L.B. Influence of common drugs and related factors on stroke outcome. Curr Opin Neurol 1997, 10:52-57.
6. Lim C.M., Kim S.W., Park J.Y., Kim C., Yoon S.H., Lee J.K. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. Neurosci Res 2009, 87:1037-1045.
7. Li W.L., Cai H.H., Wang B., et al. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 2009, 87:112-122.
8. Martinsson L., Hardemark H., Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007, 24:CD002090. [A comprehensive review on published and unpublished studies].
9. Grade C., Redford B., Chrostowski J., et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998, 79:1047-1050.
10. Tardy J., Pariente J., Leger A., et al. Methylphenidate modulates cerebral post-stroke reorganization. Neuroimage 2006, 33:913-922.
11. Platz T., Kim I.H., Engel U., et al. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double-blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 2005, 23:271-280.
12. Gladstone D.J., Danells C.J., Armesto A., et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006, 37:179-185.
13. Scheidtmann K., Fries W., Muller F., et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study. Lancet 2001, 358:787-790.
14. Sonde L., Lökk J. Effects of amphetamine and/or L-DOPA and physiotherapy after stroke: a blinded randomized study. Acta Neurol Scand 2007, 115:55-59.
15. Floel A., Hummel F., Breitenstein C., et al. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology 2005, 65:472-474.
16. Restemeyer C., Weiller C., Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled crossover pilot study. Restor Neurol Neurosci 2007, 25:143-150.
17. Rosser N., Heuschmann P., Wersching H., et al. Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil 2008, 89:1633-1641.
18. Astrom M., Adolfsson R., Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993, 24:976-982.
19. Berg A., Psych L., Palomaki H., et al. Poststroke depression-an 18-month follow-up. Stroke 2003, 34:138-143.
20. Wiart L., Petit H., Joseph P.A., Mazaux J.M., Barat M. Fluoxetine in early post-stroke depression: a double-blind placebo-controlled study. Stroke 2000, 31:1829-1832.
21. Fruehwald S., Gatterbauer E., Rehak P., Baumhackl U. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with open-label long-term follow-up. J Neurol 2003, 250:347-351.
22. Hackett M.L., Anderson C.S., House A., Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008, 4:CD003437. 10.1002/14651858.CD003437.pub3.
23. Chen Y., Patel N.C., Guo J.J., Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol 2007, 22:159-166.
24. Robinson R.G., Jorge R.E., Moser D.J., et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008, 299:2391-2400.
25. Hackett M.L., Anderson C.S., House A., Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008, 3:CD003689. 10.1002/14651858.CD003689.pub3.
26. Dam M., Tonin P., De Boni A., et al. Effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996, 27:1211-1214.
27. Pariente J., Loubinoux I., Carel C., et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001, 50:718-729.
28. Zittel S., Weiller C., Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008, 22:311-314.
29. Acler M., Robol E., Fiaschi A., Manganotti P. A double-blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 2009, 256:1152-1158.
30. Gerdelat-Mas A., Loubinoux I., Tombari D., Rascol O., Chollet F., Simonetta-Moreau M. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 2005, 27:314-322.
31. Mikami K., Jorge R.E., Adams H.P., Davis P.H., Leira E.C., Jang M., et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011, 19:1007-1015.
32. Chollet F., Tardy J., Albucher J.F., Thalamas C., Berard E., Lamy C., et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011, 10:123-130. [Epub 2011 Jan 7].